Heska Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,016.00
5,855.00
6,890.00
10,794.00
9,659.00
13,389
Total Accounts Receivable
12,609.00
12,811.00
16,444.00
20,957.00
17,780.00
20,343
Inventories
11,687.00
12,658.00
16,101.00
20,395.00
32,596.00
25,104
Other Current Assets
3,599.00
3,076.00
1,827.00
3,127.00
2,877.00
3,571
Total Current Assets
33,911.00
34,400.00
41,262.00
55,273.00
62,912.00
62,407
Net Property, Plant & Equipment
9,928.00
13,410.00
17,020.00
16,581.00
17,331.00
15,981
Long-Term Note Receivable
1,407.00
1,466.00
1,516.00
-
9,615.00
15,208
Intangible Assets
21,571.00
21,205.00
20,966.00
28,993.00
28,645.00
36,443
Other Assets
378.00
642.00
3,072.00
8,875.00
5,407.00
4,274
Total Assets
93,553.00
96,844.00
109,719.00
130,844.00
135,787.00
156,452
ST Debt & Current Portion LT Debt
4,930.00
189.00
302.00
750.00
6,000.00
Accounts Payable
4,448.00
4,897.00
7,624.00
7,154.00
9,489.00
Other Current Liabilities
8,328.00
9,966.00
10,877.00
24,510.00
10,237.00
Total Current Liabilities
17,706.00
15,052.00
18,803.00
32,414.00
25,726.00
Long-Term Debt
369.00
227.00
69.00
-
-
Deferred Taxes
26,358.00
25,721.00
25,883.00
21,122.00
11,877.00
Other Liabilities
11,298.00
12,754.00
11,572.00
11,455.00
9,621.00
Total Liabilities
29,373.00
28,033.00
30,444.00
43,869.00
35,347.00
Common Equity (Total)
47,116.00
53,132.00
63,528.00
86,975.00
100,440.00
Total Shareholders' Equity
47,116.00
53,132.00
63,528.00
86,975.00
100,440.00
Total Equity
60,775.00
68,811.00
79,275.00
86,975.00
100,440.00
Liabilities & Shareholders' Equity
93,553.00
96,844.00
109,719.00
130,844.00
135,787.00
Accumulated Minority Interest
13,659.00
15,679.00
15,747.00
-
-
Non-Equity Reserves
3,405.00
-
-
-
-

About Heska

View Profile
Address
3760 Rocky Mountain Avenue
Loveland Colorado 80538
United States
Employees -
Website http://www.heska.com
Updated 07/08/2019
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines.